Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Abzena Expands ADC Capabilities

Abzena Expands ADC Capabilities

Contract Pharma 2018-03-29

Abzena has completed the facility remodeling for its new antibody-drug conjugate (ADC) GMP manufacturing suite at its Bristol, PA site.

The facility is being equipped with state-of-the-art Sartorius and GE equipment for single use scale-up, manufacture and purification processes. The environmentally controlled suite will enable Abzena to produce ADCs for preclinical and early phase clinical studies. The suite is a significant part of Abzena's integrated ADC capabilities for the design, development and manufacture of ADCs.

The facility and equipment verification and qualification for this ADC GMP manufacturing suite is currently underway, and scheduled for completion around the end of the second quarter of 2018.

Completion of the GMP ADC manufacturing suite construction marks a key point in Abzena's program to expand the group's integrated ADC chemistry solutions. This ADC manufacturing suite complements the existing GMP manufacturing capability for the scale-up and manufacture of highly potent payload-linker constructs, and the upgrading and expansion of Abzena's biologics process development and manufacturing capabilities in San Diego. The plans are on track for the initial relocation for Abzena's biologics manufacturing process and analytical development groups into the new San Diego facility during April 2018.

Abzena has existing client process development programs scheduled for the Bristol ADC manufacturing facility including an ADC utilizing the group's proprietary ThioBridge conjugation technology and another that has benefitted from an integrated program comprising cell line development, antibody production and development and manufacture of the ADC product including the linker-payload reagent.

"The completion of this facility is a significant step in realizing Abzena's vision of being a full service and technology provider for the design, development and manufacture of ADCs," said Sanjeevani Ghone, vice president and site head, Abzena, Bristol PA. "Our recent contracts are a testament to our client's confidence in our expertise and experience in this field."

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.